Quick Answer
HOOKIPA Pharma Inc. reported Operating Income of -$51.45 million for fiscal year 2024.
HOOKIPA Pharma Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$51.45M | +47.3% |
| 2023 | -$97.69M | -33.5% |
| 2022 | -$73.16M | +10.4% |
| 2021 | -$81.67M | -53.3% |
| 2020 | -$53.28M | -4.3% |
| 2019 | -$51.09M | -141.2% |
| 2018 | -$21.18M | -49.6% |
| 2017 | -$14.16M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$17.87M | -260.9% | +4.1% |
| September 30, 2024 | -$18.64M | +17.8% | +17.0% |
| June 30, 2024 | -$22.46M | -4.6% | -302.2% |
| March 31, 2024 | $11.11M | +149.0% | +149.0% |
| September 30, 2023 | -$22.67M | -8.0% | -5.6% |
| June 30, 2023 | -$21.47M | -16.5% | +5.2% |
| March 31, 2023 | -$22.66M | -12.5% | -7.9% |
| September 30, 2022 | -$20.99M | +0.8% | -13.9% |
- HOOKIPA Pharma Inc. showed an increase of +47.3% in Operating Income compared to the prior fiscal year.
- Over the 2017–2024 period, HOOKIPA Pharma Inc.’s operating income has declined by 263.5% (from -$14.16 million to -$51.45 million).
- The most recent figure is from HOOKIPA Pharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: